Luxna Biotech Co., Ltd.

  • EN
  • JP

Luxna Biotech Co., Ltd.

  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact
ルクサナバイオテク株式会社
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact

Notice│ News

  1. HOME
  2. News
  3. Notice

Notice:Luxna Biotech and Head Office for Open Innovation Business Development Strategy, Tohoku University Announce the Initiation of the Collaborative Research for Creation of Antisense Oligonucleotide for the Treatment of Hearing Loss

  • 2023/12/22
  • Notice
Read

Notice of Option Agreement with Servier

  • 2023/12/20
  • Notice
Read

We are selected for “KSII Zebra” by the Kansai Innovation Initiative (KSII).

  • 2023/12/15
  • Notice
Read

Notification of Formulation of General Business Owner Action Plans

  • 2023/11/30
  • Notice
Read

We are selected as finalists for “Citeline Pharma Intelligence Awards Japan 2023”.

  • 2023/09/26
  • Notice
Read

Notification of Eligible Invoicing Business Registration Number

  • 2023/09/20
  • Notice
Read

The collaborative research of Luxna Biotech with Sekisui Medical CO., Ltd. on a higly-sensitve detection methods of antisense oligonucleotides has been published in the journal, the BioTechniques.

  • 2023/07/03
  • Notice
Read

We are selected as promising startup company by J-Startup.

  • 2023/04/10
  • Notice
Read

Notice of collaboration agreement for drug discovery research with Servier

  • 2023/04/06
  • Notice
Read

We have selected for The Small and Medium Enterprise Agency’s grant (2nd funding cycle) “Support Project for Research and Development of Growing Small and Medium Enterprises (Go-Tech Project)”.

  • 2022/12/27
  • Notice
Read
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Luxna Biotech Co., Ltd.

  • C907 9F Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 JAPAN
  • TEL: +81(0)6-6170-1228
  • FAX: +81(0)6-6170-2207
  • MAIL: info@luxnabiotech.co.jp
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Company Overview
  • Contact
  • Animal Experiments Policy
  • Privacy Protection Policy
  • Site Map

Copyright © 2018 Luxna Biotech Co., Ltd. All Rights Reserved.